Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA.

Chiho Komoto, Tsutomu Nakamura, Motohiro Yamamori, Nobuko Ohmoto, Hironao Kobayashi, Akiko Kuwahara, Kohshi Nishiguchi, Kohji Takara, Yusuke Tanigawara, Noboru Okamura, Katsuhiko Okumura, Toshiyuki Sakaeda

Research output: Contribution to journalArticle

Abstract

In previous reports, the effects of 12 Ca2+ antagonists on a multidrug resistant transporter, P-glycoprotein/MDR1, were evaluated in terms of those on MDR1-mediated transport of [3H]digoxin and the sensitivity of vinblastine sulfate or paclitaxel, and they were able to be classified into 4 subgroups based on their actions, as those with transport inhibition and sensitivity recovery, those with or without transport inhibition but marginal sensitivity recovery, and those without both. In this study, our previous findings were confirmed by the resistance against doxorubicin hydrochloride and daunorubicin hydrochloride, and by the recovery of [3H] vinblastine sulfate accumulation. Furthermore, it was found that the effects of 12 Ca2+ antagonists on the sensitivity recovery were also explained by the down-regulation of MDR1 mRNA, suggesting a novel mechanism to reverse the MDR1-mediated multidrug resistance.

Original languageEnglish
Pages (from-to)355-363
Number of pages9
JournalThe Kobe journal of medical sciences
Volume53
Issue number6
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Vinblastine
Multiple Drug Resistance
Down-Regulation
Messenger RNA
Daunorubicin
Digoxin
P-Glycoprotein
Paclitaxel
Doxorubicin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Komoto, C., Nakamura, T., Yamamori, M., Ohmoto, N., Kobayashi, H., Kuwahara, A., ... Sakaeda, T. (2008). Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA. The Kobe journal of medical sciences, 53(6), 355-363.

Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA. / Komoto, Chiho; Nakamura, Tsutomu; Yamamori, Motohiro; Ohmoto, Nobuko; Kobayashi, Hironao; Kuwahara, Akiko; Nishiguchi, Kohshi; Takara, Kohji; Tanigawara, Yusuke; Okamura, Noboru; Okumura, Katsuhiko; Sakaeda, Toshiyuki.

In: The Kobe journal of medical sciences, Vol. 53, No. 6, 2008, p. 355-363.

Research output: Contribution to journalArticle

Komoto, C, Nakamura, T, Yamamori, M, Ohmoto, N, Kobayashi, H, Kuwahara, A, Nishiguchi, K, Takara, K, Tanigawara, Y, Okamura, N, Okumura, K & Sakaeda, T 2008, 'Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA.', The Kobe journal of medical sciences, vol. 53, no. 6, pp. 355-363.
Komoto C, Nakamura T, Yamamori M, Ohmoto N, Kobayashi H, Kuwahara A et al. Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA. The Kobe journal of medical sciences. 2008;53(6):355-363.
Komoto, Chiho ; Nakamura, Tsutomu ; Yamamori, Motohiro ; Ohmoto, Nobuko ; Kobayashi, Hironao ; Kuwahara, Akiko ; Nishiguchi, Kohshi ; Takara, Kohji ; Tanigawara, Yusuke ; Okamura, Noboru ; Okumura, Katsuhiko ; Sakaeda, Toshiyuki. / Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA. In: The Kobe journal of medical sciences. 2008 ; Vol. 53, No. 6. pp. 355-363.
@article{abfee2d16315491ca4d3389bacff8c45,
title = "Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA.",
abstract = "In previous reports, the effects of 12 Ca2+ antagonists on a multidrug resistant transporter, P-glycoprotein/MDR1, were evaluated in terms of those on MDR1-mediated transport of [3H]digoxin and the sensitivity of vinblastine sulfate or paclitaxel, and they were able to be classified into 4 subgroups based on their actions, as those with transport inhibition and sensitivity recovery, those with or without transport inhibition but marginal sensitivity recovery, and those without both. In this study, our previous findings were confirmed by the resistance against doxorubicin hydrochloride and daunorubicin hydrochloride, and by the recovery of [3H] vinblastine sulfate accumulation. Furthermore, it was found that the effects of 12 Ca2+ antagonists on the sensitivity recovery were also explained by the down-regulation of MDR1 mRNA, suggesting a novel mechanism to reverse the MDR1-mediated multidrug resistance.",
author = "Chiho Komoto and Tsutomu Nakamura and Motohiro Yamamori and Nobuko Ohmoto and Hironao Kobayashi and Akiko Kuwahara and Kohshi Nishiguchi and Kohji Takara and Yusuke Tanigawara and Noboru Okamura and Katsuhiko Okumura and Toshiyuki Sakaeda",
year = "2008",
language = "English",
volume = "53",
pages = "355--363",
journal = "Kobe Journal of Medical Sciences",
issn = "0023-2513",
publisher = "Kobe University School of Medicine",
number = "6",

}

TY - JOUR

T1 - Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA.

AU - Komoto, Chiho

AU - Nakamura, Tsutomu

AU - Yamamori, Motohiro

AU - Ohmoto, Nobuko

AU - Kobayashi, Hironao

AU - Kuwahara, Akiko

AU - Nishiguchi, Kohshi

AU - Takara, Kohji

AU - Tanigawara, Yusuke

AU - Okamura, Noboru

AU - Okumura, Katsuhiko

AU - Sakaeda, Toshiyuki

PY - 2008

Y1 - 2008

N2 - In previous reports, the effects of 12 Ca2+ antagonists on a multidrug resistant transporter, P-glycoprotein/MDR1, were evaluated in terms of those on MDR1-mediated transport of [3H]digoxin and the sensitivity of vinblastine sulfate or paclitaxel, and they were able to be classified into 4 subgroups based on their actions, as those with transport inhibition and sensitivity recovery, those with or without transport inhibition but marginal sensitivity recovery, and those without both. In this study, our previous findings were confirmed by the resistance against doxorubicin hydrochloride and daunorubicin hydrochloride, and by the recovery of [3H] vinblastine sulfate accumulation. Furthermore, it was found that the effects of 12 Ca2+ antagonists on the sensitivity recovery were also explained by the down-regulation of MDR1 mRNA, suggesting a novel mechanism to reverse the MDR1-mediated multidrug resistance.

AB - In previous reports, the effects of 12 Ca2+ antagonists on a multidrug resistant transporter, P-glycoprotein/MDR1, were evaluated in terms of those on MDR1-mediated transport of [3H]digoxin and the sensitivity of vinblastine sulfate or paclitaxel, and they were able to be classified into 4 subgroups based on their actions, as those with transport inhibition and sensitivity recovery, those with or without transport inhibition but marginal sensitivity recovery, and those without both. In this study, our previous findings were confirmed by the resistance against doxorubicin hydrochloride and daunorubicin hydrochloride, and by the recovery of [3H] vinblastine sulfate accumulation. Furthermore, it was found that the effects of 12 Ca2+ antagonists on the sensitivity recovery were also explained by the down-regulation of MDR1 mRNA, suggesting a novel mechanism to reverse the MDR1-mediated multidrug resistance.

UR - http://www.scopus.com/inward/record.url?scp=67651245543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651245543&partnerID=8YFLogxK

M3 - Article

C2 - 18762730

VL - 53

SP - 355

EP - 363

JO - Kobe Journal of Medical Sciences

JF - Kobe Journal of Medical Sciences

SN - 0023-2513

IS - 6

ER -